Previous 10 | Next 10 |
ICU Medical, Inc. (ICUI) Q2 2022 Earnings Conference Call August 8, 2022, 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - CEO & Chairman Brian Bonnell - CFO & Treasurer Conference Call Participants Jayson Bedford - Raymond James ...
ICU Medical press release ( NASDAQ: ICUI ): Q2 Non-GAAP EPS of $1.37 misses by $0.29 . Revenue of $561M (+74.4% Y/Y) misses by $3.1M . For further details see: ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M
SAN CLEMENTE, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2022. Second Quarter 2022 Results Second ...
The U.S. Food and Drug Administration (FDA) on Wednesday classified the recall of some syringe infusion pumps by ICU Medical ( NASDAQ: ICUI ) company Smiths Medical as the most serious type. Smiths Medical in April recalled over 118K of its Medfusion 4000 and 3500 Syringe ...
SAN CLEMENTE, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2022 earnings release and conference call. The Company will release...
Recent financial performance reported by Bausch + Lomb has been encouraging from a sales perspective. However, the company's bottom line is facing continued difficulties. But given how cheap shares of the business are today, it does seem to offer some upside potential even if risk...
ICU Medical, Inc. (ICUI) Q1 2022 Earnings Conference Call May 09, 2022 04:30 PM ET Company Participants John Mills - Managing Partner Vivek Jain - Chairman & Chief Executive Officer Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Larry S...
The following slide deck was published by ICU Medical, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: ICU Medical, Inc. 2022 Q1 - Results - Earnings Call Presentation
ICU Medical press release (NASDAQ:ICUI): Q1 Non-GAAP EPS of $1.82 beats by $0.04. Revenue of $543.12M (+70.8% Y/Y) misses by $14.21M. For further details see: ICU Medical Non-GAAP EPS of $1.82 beats by $0.04, revenue of $543.12M misses by $14.21M
SAN CLEMENTE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended March 31, 2022. First Quarter 2022 Results First qu...
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...